Disease: Oxalosis
- 2022 Recommendations of the AFU Lithiasis Committee: Medical management - from diagnosis to treatment
- 2023 FDA TIDES (Peptides and Oligonucleotides) Harvest
- 24-Hour Urine Collection
- 32-year-old diabetic patient with progressive vision loss and crystalline retinopathy
- A clinical screening algorithm for primary hyperoxaluria type 1 in adults on dialysis
- A molecular journey on the pathogenesis of primary hyperoxaluria
- A plain abdominal x-ray may direct the diagnosis of primary hyperoxaluria
- A Rare Sparkle: A Case of Calcified Kidneys in a Young Infant With Renal Failure
- Anti-obesity pharmacotherapy in adults with chronic kidney disease
- Bariatric surgery in prospective obese living kidney donors: scoping review and management decision algorithm
- Bone health in children with primary hyperoxaluria type 1 following liver and kidney transplantation
- Carrier frequency estimation of pathogenic variants of autosomal recessive and X-linked recessive mendelian disorders using exome sequencing data in 1,642 Thais
- Case Report: effect of lumasiran treatment in a late preterm baby with antenatal diagnosis of primary hyperoxaluria type 1
- Case series and literature review of primary hyperoxaluria type 1 in Chinese patients
- Children With Type 1 Spinal Muscular Atrophy Are at Increased Risk for Nephrolithiasis
- Circulating Oxalate Levels in Short Bowel Syndrome as a Severity Marker of CKD
- Clinical characteristics, genetic profile and short-term outcomes of children with primary hyperoxaluria type 2: a nationwide experience
- Clinicopathologic Characteristics, Etiologies, and Outcome of Secondary Oxalate Nephropathy
- Combined liver-kidney transplantation in pediatric patients
- Comprehensive evaluation of patients with primary hyperoxaluria type 1: A nationwide study
- Contrasting Response of Urine Stone Risk to Medical Treatment in Calcium Oxalate versus Calcium Phosphate Stone Formers
- Correction: Lumasiran: A Review in Primary Hyperoxaluria Type 1
- Determinants and impact of calcium oxalate crystal deposition on renal outcomes in acute kidney injury patients
- Determinants of Kidney Failure in Primary Hyperoxaluria Type 1: Findings of the European Hyperoxaluria Consortium
- Distinguishing characteristics of pediatric patients with primary hyperoxaluria type 1 in PEDSnet
- Drivers of calcium oxalate stone formation in the octogenarian population
- Efficient and safe therapeutic use of paired Cas9-nickases for primary hyperoxaluria type 1
- Ethanolic extract of cotinuscoggygria leaves attenuates crystalluria and kidney damage in ethylene glycol-induced urolithiasis in rats
- Exosomes from miR-23 Overexpressing Stromal Cells Suppress M1 Macrophage and Inhibit Calcium Oxalate Deposition in Hyperoxaluria Rat Model
- Expanding the Genetic Spectrum of AGXT Gene Variants in Egyptian Patients with Primary Hyperoxaluria Type I
- Gene editing: a near future for the treatment of genetic kidney diseases
- Glycolate oxidase-1 gene variants influence the risk of hyperoxaluria and renal stone development
- Glyoxylate reductase: Definitive identification in human liver mitochondria, its importance for the compartment-specific detoxification of glyoxylate
- Herbo-Mineral Medicine, Lithom Exhibits Anti-Nephrolithiasis Activity in Rat Model of Hyperoxaluria by Attenuating Calcium Oxalate Crystal Formation and Oxidative Stress
- Histologic and Clinical Factors Associated with Kidney Outcomes in IgA Vasculitis Nephritis
- Histone deacetylase 6 suppression of renal tubular epithelial cell promotes interstitial mineral deposition via alpha-tubulin acetylation
- How We Treat Primary Hyperoxaluria Type 1
- Hydration for Adult Patients with Nephrolithiasis: Specificities and Current Recommendations
- Hypercalcemia in an Infant with Primary Hyperoxaluria Type 2: A Novel Association
- Hyperoxaluria - A Major Metabolic Risk for Kidney Stone Disease
- In vivo base editing rescues primary hyperoxaluria type 1 in rats
- Insights into the pathogenesis of primary hyperoxaluria type I from the structural dynamics of alanine:glyoxylate aminotransferase variants
- Intestinal Oxalate Absorption, Enteric Hyperoxaluria, and Risk of Urinary Stone Formation in Patients with Crohn's Disease
- Is Genotype the Major Outcome Parameter of Kidney Failure in Patients With Primary Hyperoxaluria Type 1?
- Late Presentation of Primary Oxalosis, Microcrystalline Arthropathy, and Tumoral Calcinosis: A Case Report and a Literature Review
- Localized calcium oxalate crystals in primary cutaneous aspergillosis
- Long-Term Sodium Deficiency Reduces Sodium Excretion but Impairs Renal Function and Increases Stone Formation in Hyperoxaluric Calcium Oxalate Rats
- Lumasiran: A Review in Primary Hyperoxaluria Type 1
- Metabolic evaluation of first-time uncomplicated renal stone formers: A prospective study
- Multicenter Long-Term Real World Data on Treatment With Lumasiran in Patients With Primary Hyperoxaluria Type 1
- Multimodal Imaging Findings Associated With Cardiac Oxalosis Cardiomyopathy
- Multiplex gene editing reduces oxalate production in primary hyperoxaluria type 1
- N-acetylcysteine regulates oxalate induced injury of renal tubular epithelial cells through CDKN2B/TGF-β/SMAD axis
- Nanoparticles and siRNA: A new era in therapeutics?
- Nedosiran: First Approval
- Nephrocalcinosis
- Nephrocalcinosis can disappear in infants receiving early lumasiran therapy
- Nephrocalcinosis in a Transplanted Kidney: A New Sign of Chronic Tacrolimus Nephrotoxicity
- Nephrology picture: metabolic acidosis with acute tubular injury-a noteworthy case
- Ocular manifestations of the genetic renal tubulopathies
- Ophthalmic Sequelae of Late-Stage Primary Hyperoxaluria Type 1
- Oxalate (dys)Metabolism: Person-to-Person Variability, Kidney and Cardiometabolic Toxicity
- Oxalate nephropathy after pancreaticoduodenectomy: a case report
- Oxalate nephropathy and chronic turmeric supplementation: a case report
- Oxalate nephropathy and chronic turmeric supplementation: a case report
- Oxalate Nephropathy and the Mechanism of Oxalate-Induced Kidney Injury
- Oxalate Nephropathy: A Case Report of Acute Kidney Injury Due to Juice Diet
- Palmar papules as a manifestation of cutaneous oxalosis in primary hyperoxaluria: A case report and review of the literature
- Pathophysiology and management of enteric hyperoxaluria
- Pediatric renal lithiasis in Spain: research, diagnostic and therapeutic challenges, and perspectives
- Personalized Medicine in Urolithiasis: AI Chatbot-Assisted Dietary Management of Oxalate for Kidney Stone Prevention
- Prevalence and characteristics of genetic disease in adult kidney stone formers
- Primary hyperoxaluria detected by bone marrow biopsy: A case report
- Primary Hyperoxaluria Screening and Monitoring: Quantitative Measurement of Plasma Oxalate by Gas Chromatography-Mass Spectrometry With High Sensitivity
- Primary hyperoxaluria type 1-a rare hereditary metabolic disorder as cause of livedo racemosa
- Primary hyperoxaluria type 1: Clinical, genetic, and evolutionary characteristics in Tunisian children
- Primary hyperoxaluria: a case series
- Primary hyperoxaluria: Description of a new oral finding and review of literature
- Qualitative assessment of the patient experience of primary hyperoxaluria type 1: an observational study
- Recent Advances of Oxalate Decarboxylase: Biochemical Characteristics, Catalysis Mechanisms, and Gene Expression and Regulation
- Recurrent disease after pediatric renal transplantation
- Resolution of Crystalline Retinopathy After Kidney Transplant for Hyperoxaluria
- Restored glyoxylate metabolism after AGXT gene correction and direct reprogramming of primary hyperoxaluria type 1 fibroblasts
- Review of childhood genetic nephrolithiasis and nephrocalcinosis
- Risk factors for recurrence in pediatric urinary stone disease
- RNA nanomedicine in liver diseases
- RNA therapeutics for disorders of excretory system
- RNA therapeutics for metabolic disorders
- Simultaneous Detection of Citric Acid and Oxalic Acid Based on Dual Spectrum and Biomimetic Peroxidase for Urolithiasis Screening with a Fully Automatic Urine Analyzer
- Small Interfering RNA (siRNA) Therapy
- Targeting the Liver with Nucleic Acid Therapeutics for the Treatment of Systemic Diseases of Liver Origin
- Tartronic Acid as a Potential Inhibitor of Pathological Calcium Oxalate Crystallization
- The Clinical and Pathological Characteristics of Patients with Oxalate Nephropathy
- The intestinal microbiome of children with initial and recurrent nephrolithiasis: A pilot study and exploratory analysis
- The Potential of NOD-like Receptor Protein 3 Inflammasome Inhibitors in the Treatments of Diseases
- The protective effect of caffeine against oxalate-induced epithelial-mesenchymal transition in renal tubular cells via mitochondrial preservation
- Unity Is Strength: The Mutual Alliance between CFTR and SLC26A6 as Therapeutic Opportunity in Cystic Fibrosis
- Urolithiasis in children; The importance of stone localization in treatment and follow-up
- Urolithiasis: History, epidemiology, aetiologic factors and management
- Young Male With End-Stage Renal Disease Due to Primary Hyperoxaluria Type 2: A Rare Presentation